Catalyst Wire Dossier Catalyst Wire Dossier

Kamada-API

alpha-1 proteinase inhibitor · Kamada Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kamada-API, covering 2007-10-17 to 2007-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency [Phase 2, Phase 3]

See pricing